Jelica Bjekic-Macut

Jelica Bjekic-Macut

Auto-generated profile, based on publicly available information

Jelica Bjekic-Macut

Department of Endocrinology, University Hospital, Belgrade, Serbia

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
TMTatjana Milenkovic
Tatjana Milenkovic
NBNadica Bozhinovska
Nadica Bozhinovska
DMDjuro Macut
Djuro Macut
JBJelica Bjekic-Macut
Jelica Bjekic-Macut
Dario RahelićDario Rahelić
Dario Rahelić
ABAzra Burekovic
Azra Burekovic
For the past 80 years, the effect of the Mediterranean diet on overall health has been a constant topic of interest among medical and scientific researchers. Parallel with the persistent global rise of cases of type 2 diabetes, many studies conducted in the past 20 years have shown the benefits of the Mediterranean lifestyle for people with, or at risk of developing, type 2 diabetes mellitus. However, despite the large body of evidence, concerns exist amongst scientists regarding the reliability of the data related to this topic. This review offers a glimpse of the onset of the Mediterranean diet and follows its significant impact on the prevention and treatment of type 2 diabetes. There is a constant rise in type 2 diabetes cases on the Balkan Peninsula and North Macedonia in particular. Having in mind that North Macedonia, as well as most of the countries on the Balkans have low to middle income, there is a need for a certain affordable dietary pattern to ameliorate the rise in diabetes incidence, as well as improve the glycemic control. We did a review based on the available literature regarding Mediterranean diet and people with or at risk of developing type 2 diabetes mellitus, its effects on glycemic control, lipid profile and metabolic outcome.

1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
VPViseslav Popadic
Viseslav Popadic
SKSlobodan Klasnja
Slobodan Klasnja
Natasa MilicNatasa Milic
Natasa Milic
NRNina Rajovic
Nina Rajovic
AAAleksandra Aleksic
Aleksandra Aleksic
Marija ZdravkovićMarija Zdravković
Marija Zdravković
Introduction. Mortality among critically ill COVID‐19 patients remains relatively high despite different potential therapeutic modalities being introduced recently. The treatment of critically ill patients is a challenging task, without identified credible predictors of mortality. Methods. We performed an analysis of 160 consecutive patients with confirmed COVID‐19 infection admitted to the Respiratory Intensive Care Unit between June 23, 2020, and October 2, 2020, in University Hospital Center Bezanijska kosa, Belgrade, Serbia. Patients on invasive, noninvasive ventilation and high flow oxygen therapy with moderate to severe ARDS, according to the Berlin definition of ARDS, were selected for the study. Demographic data, past medical history, laboratory values, and CT severity score were analyzed to identify predictors of mortality. Univariate and multivariate logistic regression models were used to assess potential predictors of mortality in critically ill COVID‐19 patients. Results. The mean patient age was 65.6 years (range, 29–92 years), predominantly men, 68.8%. 107 (66.9%) patients were on invasive mechanical ventilation, 31 (19.3%) on noninvasive, and 22 (13.8%) on high flow oxygen therapy machine. The median total number of ICU days was 10 (25th to 75th percentile: 6–18), while the median total number of hospital stay was 18 (25th to 75th percentile: 12–28). The mortality rate was 60% (96/160). Univariate logistic regression analysis confirmed the significance of age, CRP, and lymphocytes at admission to hospital, serum albumin, D‐dimer, and IL‐6 at admission to ICU, and CT score. Serum albumin, D‐dimer, and IL‐6 at admission to ICU were independently associated with mortality in the final multivariate analysis. Conclusion. In the present study of 160 consecutive critically ill COVID‐19 patients with moderate to severe ARDS, IL‐6, serum albumin, and D‐dimer at admission to ICU, accompanied by chest CT severity score, were marked as independent predictors of mortality.

1 October 2021 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
JBJelica Bjekić-Macut
Jelica Bjekić-Macut
TVTamara Vukašin
Tamara Vukašin
ZVZelija Velija-Ašimi
Zelija Velija-Ašimi
ABAzra Bureković
Azra Bureković
Marija ZdravkovićMarija Zdravković
Marija Zdravković
George MastorakosGeorge Mastorakos
George Mastorakos
Polycystic ovary syndrome (PCOS) is a frequent endocrine disease in women during the reproductive period. It is considered a complex metabolic disorder with long-term metabolic, as well as reproductive consequences. Main pathophysiological pathways are related to the increased androgen levels and insulin resistance. Nowadays, genetic origins of PCOS are acknowledged, with numerous genes involved in the pathogenesis of hyperandrogenemia, insulin resistance, inflammation, and disturbed folliculogenesis. Rotterdam diagnostic criteria are most widely accepted and four PCOS phenotypes have been recognized. Metabolic abnormalities are more common in phenotypes 1 and 2. Women with classic PCOS are more obese and typically have the central type of obesity, more prevalently displaying dyslipidemia, insulin resistance, and metabolic syndrome that could be associated with an increased risk of cardiovascular complications during life. Heterogeneity of phenotypes demands an individualized approach in the treatment of women with PCOS. Metabolic therapies involve a lifestyle intervention followed by the introduction of insulin sensitizers including metformin and inositols, glucagon-like peptide 1 receptor agonists (GLP-1 RA), as recently sodium-glucose cotransporter-2 (SGLT2) inhibitors. The addition of an insulin sensitizer to the standard infertility therapy such as clomiphene citrate improves ovulation and pregnancy rates. Our current review analyzes the contemporary knowledge of PCOS etiology and etiopathogenesis, its cardiometabolic risks and their outcomes, as well as therapeutic advances for women with PCOS.

Verified
Journal Article
Open access
PDF file
Zoran TodorovicZoran Todorovic
Zoran Todorovic
SĐSiniša Đurašević
Siniša Đurašević
Maja StojkovicMaja Stojkovic
Maja Stojkovic
IGIlijana Grigorov
Ilijana Grigorov
Sladjan PavlovicSladjan Pavlovic
Sladjan Pavlovic
JDJelena Djordjevic
Jelena Djordjevic
Lipids play an essential role in both tissue protection and damage. Tissue ischemia creates anaerobic conditions in which enzyme inactivation occurs, and reperfusion can initiate oxidative stress that leads to harmful changes in membrane lipids, the formation of aldehydes, and chain damage until cell death. The critical event in such a series of harmful events in the cell is the unwanted accumulation of fatty acids that leads to lipotoxicity. Lipid analysis provides additional insight into the pathogenesis of ischemia/reperfusion (I/R) disorders and reveals new targets for drug action. The profile of changes in the composition of fatty acids in the cell, as well as the time course of these changes, indicate both the mechanism of damage and new therapeutic possibilities. A therapeutic approach to reperfusion lipotoxicity involves attenuation of fatty acids overload, i.e., their transport to adipose tissue and/or inhibition of the adverse effects of fatty acids on cell damage and death. The latter option involves using PPAR agonists and drugs that modulate the transport of fatty acids via carnitine into the interior of the mitochondria or the redirection of long-chain fatty acids to peroxisomes.

14 June 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
SLSarantis Livadas
Sarantis Livadas
RPRodis D. Paparodis
Rodis D. Paparodis
Panagiotis AnagnostisPanagiotis Anagnostis
Panagiotis Anagnostis
AGAlessandra Gambineri
Alessandra Gambineri
JBJelica Bjekić-Macut
Jelica Bjekić-Macut
DMDjuro Macut
Djuro Macut
Women with polycystic ovary syndrome (PCOS) are at increased risk for dysglycemia and type 2 diabetes compared to healthy BMI-matched women of reproductive age: robust evidence exists supporting this notion. The presence of altered glycemic status in young women with the syndrome presents a distinct challenge for the clinician for several reasons. Firstly, the reported incidence of this disorder varies among the limited available studies. Furthermore, there is a lack of consensus on the best screening method, which women to screen, at what frequency, and which strategies need to be implemented to reduce the above risk. We provide data regarding the prevalence of dysglycemia in young women suffering from PCOS and the pathophysiological mechanisms underlying the disorder. In addition, we present evidence suggesting universal screening with the oral glucose tolerance test in young women with the syndrome, irrespective of age or BMI status, to identify and manage glycemic abnormalities in a timely manner. Regarding follow-up, oral glucose testing should be carried out at regular intervals if there are initial abnormal findings or predisposing factors. Finally, the efficacy of a well-balanced diet in conjunction with regular exercise and the use of non-pharmacologic agents in this specific population is discussed.

1 May 2014 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
STSnezana Tepavcevic
Snezana Tepavcevic
Danijela Vojnović MilutinovićDanijela Vojnović Milutinović
Danijela Vojnović Milutinović
DMDjuro Macut
Djuro Macut
ZŽZorica Žakula
Zorica Žakula
MNMarina Nikolić
Marina Nikolić
GKGoran Korićanac
Goran Korićanac